BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the SiroLimus Eluting Orsiro Stent Within Daily Clinical Practice in Small Vessels
Latest Information Update: 21 Feb 2024
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms BIOFLOW-SV
- Sponsors BIOTRONIK
- 14 Feb 2024 Status changed from recruiting to discontinued (Problem with enrollment due to Covid-19).
- 12 Sep 2018 Planned End Date changed from 1 May 2020 to 1 Aug 2020.
- 12 Sep 2018 Planned primary completion date changed from 1 May 2019 to 1 Aug 2019.